Biochemical markers of bone turnover I: Theoretical considerations and clinical use in osteoporosis

The American Journal of Medicine

Volumn 95, Issue 5 SUPPL. 1, 1993, Pages

  Delmas, Pierre D ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; HYDROXYLYSINE; HYDROXYPROLINE; OSTEOCALCIN; PROCOLLAGEN; PYRIDINIUM DERIVATIVE;

BLOOD LEVEL; BONE MATRIX; BONE TURNOVER; CALCIUM URINE LEVEL; CROSS LINKING; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME LOCALIZATION; HIP FRACTURE; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RISK FACTOR; URINE LEVEL;

ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CALCIUM; FEMALE; HIP FRACTURES; HUMAN; HYDROXYPROLINE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 0027381657     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(93)90375-Y     Document Type: Article

References (40)

1. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis
2. Bone turnover in spinal osteoporosis
3. The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase
4. New biochemical marker for bone metabolism
5. Effect of renal function on plasma levels of bone Gla-protein
6. New biochemical marker for bone metabolism
7. Origin of vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone
8. Biochemical markers of bone turnover for the clinical assessment of metabolic disease
9. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
10. Immunoreactive forms of circulating human osteocalcin
11. Multiple immunoreactive forms in uremic serum
12. Comparison of monoclonal and polyclonal antibody-based immunoassays for osteocalcin
13. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay
14. Serum bone Gla-protein (osteocalcin) in primary hyperparathyroidism and in malignant hypercalcemia
15. Procollagen Type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone
16. The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen
17. Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells
18. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases
19. Hydroxyproline and the metabolism of collagen
20. Collagen crosslinking amino-acids
21. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks
22. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption
23. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
24. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
25. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone disease
26. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers
27. Anomalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis
28. An immunoassay to urinary pyridinoline: the new marker of bone resorption
29. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine
30. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation
31. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation
32. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
33. Plasma BGP: an indicator of spontaneous bone loss and effect of estrogen treatment in postmenopausal women
34. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study
35. Bone turnover in postmenopausal osteoporosis
36. Effect of moderate physical training on prednisone-induced protein wasting: a study of whole bone and bone protein metabolism
37. Increased bone resorption and decreased bone formation in elderly women with hip fracture
38. Increased bone resorption and decreased bone formation in elderly women with hip fracture
39. Impaired carboxylation of serum osteocalcin in elderly women
40. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women